BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37993586)

  • 1. NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic lymphocytic leukemia.
    Shang CY; Bei LY; Wu JZ; Sheng HR; Yin H; Liang JH; Wang L; Li JY; Li Y; Xu W
    Ann Hematol; 2024 Mar; 103(3):833-841. PubMed ID: 37993586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of HBV infection in chronic lymphocytic leukemia.
    Liang JH; Gao R; Dai JC; Gale RP; Li W; Fan L; Hu ZB; Xu W; Li JY
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1309-1315. PubMed ID: 29761374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
    Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
    Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
    Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
    Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
    Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
    Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients.
    Willander K; Dutta RK; Ungerbäck J; Gunnarsson R; Juliusson G; Fredrikson M; Linderholm M; Söderkvist P
    BMC Cancer; 2013 Jun; 13():274. PubMed ID: 23734977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
    De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
    Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Notch signal pathway and chronic lymphocytic leukemia].
    Zhang JY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1472-5. PubMed ID: 25338610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables.
    Qin S; Fan L; Liang J; Gale R; Miao Y; Wu Y; Wang R; Yang H; Wu W; Xia Y; Wu J; Zhu H; Wang L; Xu W; Li J
    Hematol Oncol; 2018 Oct; 36(4):656-662. PubMed ID: 29901220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
    Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
    Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation.
    Yang S; Zhu R; Li N; Feng Y; Zuo R; Gale RP; Huang X
    Acta Haematol; 2022; 145(1):54-62. PubMed ID: 34569486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia.
    Rossi D; Sala L; Minisini R; Fabris C; Falleti E; Cerri M; Burlone ME; Toniutto P; Gaidano G; Pirisi M
    Leuk Lymphoma; 2009 Apr; 50(4):604-11. PubMed ID: 19373659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
    De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
    Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
    Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
    Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
    López-Guerra M; Xargay-Torrent S; Rosich L; Montraveta A; Roldán J; Matas-Céspedes A; Villamor N; Aymerich M; López-Otín C; Pérez-Galán P; Roué G; Campo E; Colomer D
    Leukemia; 2015 Jan; 29(1):96-106. PubMed ID: 24781018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
    Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
    Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
    López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
    Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling promotes disease initiation and progression in murine chronic lymphocytic leukemia.
    Tardivon D; Antoszewski M; Zangger N; Nkosi M; Sordet-Dessimoz J; Hendriks R; Koch U; Radtke F
    Blood; 2021 Jun; 137(22):3079-3092. PubMed ID: 33512383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
    Fabbri G; Rasi S; Rossi D; Trifonov V; Khiabanian H; Ma J; Grunn A; Fangazio M; Capello D; Monti S; Cresta S; Gargiulo E; Forconi F; Guarini A; Arcaini L; Paulli M; Laurenti L; Larocca LM; Marasca R; Gattei V; Oscier D; Bertoni F; Mullighan CG; Foá R; Pasqualucci L; Rabadan R; Dalla-Favera R; Gaidano G
    J Exp Med; 2011 Jul; 208(7):1389-401. PubMed ID: 21670202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
    Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
    Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.